PSA now 4.20, down from 7.58 in late November, 2018
Below is my husband's signature showing his history. Due to rapid doubling in PSA last summer, he restarted Lupron in September, 2018 then added Zytiga/Prednisone 2/9/2019, three weeks ago. PSA is going in the right direction. He got the report after our visit with his oncologist, Dr. Matthew Smith, so we didn't get a chance to discuss if this is a decent drop, but we'll take it! It's probably too early, right, for the Zytiga to have really kicked in? He's on a monthly schedule and will see Dr. Smith in early April.
It's only been a few weeks, but so far he's tolerating the Zytiga/Prednisone with no additional side effects than the usual fatigue and mild hot flashes.
Husband 70 yrs (74 now) pacemaker; Agent Orange
9/14: blood in urine; DRE suspicious
11/14: biopsy G 9 (4+5), PSA: 3.32 high Gleason, low PSA, PNI involved
Lupron taken for 33 mos (currently on Lupron again after a year hiatus.)
6/15: 9 wks IMRT
9/15= .14
1/16= .093
4/16= .079
11/16=.05 (nadir)
2/17-5/17=.05
1
1/17= .08
2/18= .20
4/18=0.98
6/18= 3-4 bone mets seen on CT scan
7/18= 3.29
8/28= 9.0
Lupron re-started with a month of Casodex
11/27/18=7.0
Zytiga/Prednisone started 2/19
2/9/19=4.02